New FDA approval for EGFR exon 19 and exon 21 L858R

octubre 9, 2024

Posted in FDA News, Science Made SimpleTagged #sciencemadesimple, EGFR, FDA

FDA approves alectinib for ALK+ NSCLC

may 14, 2024

Posted in FDA News, Research, Science Made SimpleTagged #sciencemadesimple, ALK

Recent FDA approval of combined therapy for initial treatment of EGFR-mutated NSCLC

marzo 15, 2024

Posted in FDA News, Research, Science Made SimpleTagged #fdaapprovals, #sciencemadesimple

FDA approves repotrectinib for patients with advanced ROS-1 fusion non-small cell lung cancer

enero 12, 2024

Posted in FDA News, Research, Science Made SimpleTagged #sciencemadesimple

FDA grants accelerated approval to adagrasib for KRAS G12C-mutated NSCLC

diciembre 30, 2022

Posted in FDA News, Research, Science Made SimpleTagged #sciencemadesimple

FDA approves Imjudo with Imfinzi and chemo

noviembre 22, 2022

Posted in FDA News, Research, Science Made SimpleTagged #sciencemadesimple

FDA approves drug for HER-2 unresectable or metastatic NSCLC

agosto 23, 2022

Posted in FDA News, Research, Science Made SimpleTagged #fdaapprovals, #sciencemadesimple, HER2

FDA approves nivolumab with chemotherapy as neoadjuvant treatment for certain patients with resectable NSCLC

marzo 7, 2022

Posted in FDA News, ResearchTagged #fdaapprovals, Research

Teliso-V granted FDA Breakthrough Designation for NSCLC

enero 11, 2022

Posted in FDA News

2021 FDA approvals for lung cancer treatment

enero 4, 2022

Posted in FDA NewsTagged #inthenews